Challenges and Priorities for Research
Brian W. McCrindle(University of Toronto), Jonathan R. Kaltman(National Institutes of Health), Rebecca Ichord(Bristol-Myers Squibb (Germany)), Kenneth W. Mahaffey(Cardiovascular Institute of the South), Rajesh Krishnamurthy(Baylor College of Medicine), Alan D. Michelson(University of Nottingham), Jane W. Newburger(Greenville College), Therese M. Giglia(Children's Hospital of Philadelphia), Ron Portman(United States Food and Drug Administration), James S. Tweddell(Children's Hospital of Wisconsin), Paul Monagle(Murdoch Children's Research Institute), Leonardo R. Brandão(Hospital for Sick Children), Thomas L. Ortel(Duke University), Anthony K.C. Chan(McMaster Children's Hospital), Nicole Verdun(Center for Biologics Evaluation and Research), John Strony(Merck & Co., Inc., Rahway, NJ, USA (United States)), Cedric Manlhiot(George Washington University Hospital), Marilyn J. Manco‐Johnson(Rocky Mountain Diabetes and Osteoporosis Center), M. Patricia Massicotte(University of Toronto), Charles T. Esmon(Howard Hughes Medical Institute), Jennifer S. Li(Duke University), Martin Rose(University of Toronto), Christopher S. Almond(Boston Children's Hospital)
Cited by 34
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k